Search

Search Results

1. Cost-Effectiveness of the Second COVID-19 Booster Vaccination in the USA

   Objective

   To assess the cost effectiveness of the second COVID-19 booster vaccination with different age groups.

   Methods

   We developed a...

   Rui Li, Pengyi Lu, ... Lei Zhang in Applied Health Economics and Health Policy

   Article 01 November 2023
   

2. Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China

   Introduction

   Dolutegravir (DTG)-based regimen was included in the expanded formulary of China's National Free Antiretroviral Treatment Program at the...

   Min Li, Yuxin Cao, ... Xun Zhuang in BMC Public Health

   Article Open access 13 November 2023
   

3. Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis

   Background

   Globally, 257 million people have chronic hepatitis. Even though a safe and effective prophylactic vaccine against HBV infection has been...

   Mekuanint Geta, Endalew Yizengaw, Tsegahun Manyazewal in BMC Pediatrics

   Article Open access 28 February 2024
   

4. Common treatment strategies for calcium hydroxyapatite deposition disease: a cost-effectiveness analysis

   Objective

   To determine the cost-effectiveness of rotator cuff hydroxyapatite deposition disease (HADD) treatments.

   Method

   A 1-year time horizon...

   Erin F. Alaia, Naveen Subhas, ... Soterios Gyftopoulos in Skeletal Radiology

   Article 14 August 2023
   

5. Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer

   Background

   Colorectal cancer is a significant health concern worldwide, with metastatic CRC (mCRC) presenting a particularly challenging prognosis....

   Zijia Huang, Lingyan Zhou, ... Mei Zhan in International Journal of Clinical Pharmacy

   Article 20 April 2024
   

6. A cluster-randomized study to evaluate the effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in South Tyrolean primary care for patients with COPD, asthma, type 2 diabetes, and heart failure: the ABCC South Tyrol study

   Background

   Chronic diseases, such as chronic obstructive pulmonary disease (COPD), asthma, type 2 diabetes, and heart failure, often coexist and...

   Christian J. Wiedermann, Pasqualina Marino, ... Annerika H. M. Gidding-Slok in Trials

   Article Open access 20 March 2024

7. Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece

   Background and Objective

   Ankylosing spondylitis is a chronic, progressive, inflammatory, multidimensional, musculoskeletal disease primarily involving...

   George Gourzoulidis, Argyro Solakidi, ... Charalampos Tzanetakos in Clinical Drug Investigation

   Article 16 December 2023
   

8. Effectiveness of artificial intelligence screening in preventing vision loss from diabetes: a policy model

   The effectiveness of using artificial intelligence (AI) systems to perform diabetic retinal exams (‘screening’) on preventing vision loss is not...

   Roomasa Channa, Risa M. Wolf, ... Harold P. Lehmann in npj Digital Medicine

   Article Open access 27 March 2023
   

9. A Network Meta-analysis to Explore the Effectiveness of the Different Treatment Modalities in Acne Scars

   Background

   Multiple treatments are used to treat acne scars, but comparing the effectiveness of these treatments have not been studied yet. This...

   Min Jiang, Tian Liu, ... Jia** Zhang in Aesthetic Plastic Surgery

   Article 05 February 2024
   

10. De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis—Modeling Approach and Validation

    Background

    Nonalcoholic steatohepatitis (NASH) is a chronic liver disease associated with hepatic morbidity and mortality and extra-hepatic...

    Peter Gal, Gyorgyi Feldmajer, ... Inger Smith in PharmacoEconomics

    Article Open access 28 July 2023
    

11. Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules

    Background

    Thyroid nodules affect up to 65% of the population. Although fine needle aspirate (FNA) cytology is the gold standard for diagnosis, 15–30%...

    Navjit Dharampal, Kristine Smith, ... Shamir Chandarana in Journal of Otolaryngology - Head & Neck Surgery

    Article Open access 21 December 2022
    

12. Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China

    Background

    Glioblastoma (GBM) stands as the most aggressive and prevalent primary brain malignancy. Tumor Treating Fields (TTFields), an innovative...

    Yuliang **ang, Yingyao Chen, ... Shimeng Liu in Journal of Neuro-Oncology

    Article 02 April 2024
    

13. Cost-effectiveness analysis of robot-assisted gait training in patients with bilateral spastic cerebral palsy

    Background

    To date, there have been no published studies evaluating the cost-effectiveness of robot-assisted gait training (RAGT) in adolescent and...

    Stanislava Klobucká, Robert Klobucký, ... Branislav Kollár in Cost Effectiveness and Resource Allocation

    Article Open access 11 September 2023
    

14. Real-World Effectiveness and Safety of Tixagevimab–Cilgavimab: A Target Trial Emulation Study

    Background

    Immunocompromised individuals are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and subsequent...

    Vincent Ka Chun Yan, Yu Yang, ... Esther Wai Yin Chan in Drug Safety

    Article Open access 25 June 2024
    

15. Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran

    Introduction

    Ceftazidime avibactam (CA) is an effective treatment against carbapenem-resistant Enterobacteriaceae (CRE), but its cost-effectiveness is...

    Zahra Goudarzi, Fattaneh Danayi, ... Ahmad Gholami in Cost Effectiveness and Resource Allocation

    Article Open access 24 July 2023
    

16. The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice

    A cost-effectiveness analysis has become an important method to inform allocation decisions and reimbursement of new technologies in healthcare. A...

    Bram Wouterse, Pieter van Baal, ... Werner Brouwer in PharmacoEconomics

    Article Open access 18 April 2023

17. Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review

    Background

    Globally the burden of heart failure is rising. Hospitalisation is one of the main contributors to the burden of heart failure and...

    Andrea Driscoll, Lan Gao, Jennifer J. Watts in BMC Cardiovascular Disorders

    Article Open access 22 February 2022
    

18. Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis

    Aim

    The aim of this work was to evaluate the cost-effectiveness of faricimab against relevant therapeutic alternatives used in clinical practice for...

    Christian Bührer, Thomas Paling, ... Marloes Bagijn in PharmacoEconomics - Open

    Article Open access 04 March 2024
    

19. A principled approach to non-discrimination in cost-effectiveness

    The US Inflation Reduction Act (IRA) prohibits the Centers for Medicare and Medicaid Services (CMS) from using standard quality-adjusted life-years...

    Darius N. Lakdawalla, Jason N. Doctor in The European Journal of Health Economics

    Article Open access 27 February 2024
    

20. Map** the effectiveness of the community tuberculosis care programs: a systematic review

    Background

    Tuberculosis is a significant global public health threat, especially in countries with limited resources. To improve tuberculosis care,...

    Gabalape Arnold Sejie, Ozayr H. Mahomed in Systematic Reviews

    Article Open access 03 August 2023